Kinaptic Overview

Status Private
Employees 4
Latest Deal Type Seed
Latest Deal Amount $113K
Latest Deal Amount
Investors 1

Kinaptic General Information


Developer of a revolutionary wearable system designed to be applied to multiple markets. The company's revolutionary wearable system is releasing a unique, non-opioid based pain mitigation device based on TENS (Transcutaneous Electrical Nerve Stimulation) technology, enabling users to avail unique, portable, affordable TENS Therapy System and continue with their daily activities while enjoying the soothing benefits of TENS.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Therapeutic Devices
Other Industries
Application Software
Primary Office
  • 30 Renees Way
  • Madison, CT 06443
  • United States
+1 (860) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kinaptic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 21-Nov-2017 $113K 00000 Completed Generating Revenue
1. Seed Round Completed Generating Revenue

Kinaptic Executive Team (2)

Name Title Board Seat Contact Info
John Daniels JD Co-Founder, Chairman & Chief Technology Officer
Joseph Curcio Co-Founder & Chief Executive Officer

Kinaptic Board Members (1)

Name Representing Role Since
John Daniels JD Kinaptic Co-Founder, Chairman & Chief Technology Officer 000 0000

Kinaptic Investors (1)

To view Kinaptic‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Connecticut Innovations Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial